| Literature DB >> 25419107 |
Ercument Gurluler1, Ibrahim Berber1, Ulkem Cakir1, Alihan Gurkan1.
Abstract
BACKGROUND AND OBJECTIVES: The aim of this retrospective study was to compare conventional laparoscopic living-donor nephrectomy with transvaginal natural orifice transluminal endoscopic surgery-assisted living-donor nephrectomy in terms of feasibility and reproducibility.Entities:
Keywords: Laparoscopy approach; Living-donor nephrectomy; Transvaginal laparoscopy
Mesh:
Year: 2014 PMID: 25419107 PMCID: PMC4236079 DOI: 10.4293/JSLS.2014.00156
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Donor and Receiver Characteristics in Laparoscopic Versus Transvaginal Nephrectomy Groups
| LLDN[ | TVNALDN[ | ||||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Median (Minimum-Maximum) | n (%) | Mean (SD) | Median (Minimum-Maximum) | n (%) | ||
| Donor characteristics | |||||||
| Age (y) | 48.2 (12.2) | 48 (26–75) | 46.9 (11.0) | 46 (30–78) | .559 | ||
| BMI[ | 30.5 (5.2) | 31 (20.5–41.0) | 30.3 (4.1) | 30 (22.5–39.9) | .998 | ||
| PO[ | 0.60 (0.12) | 0.60 (0.29–0.93) | 0.60 (0.10) | 0.60 (0.42–0.78) | .069 | ||
| Obesity (BMI ≥30 kg/m2) | 37 (52.9) | 23 (51.1) | .855 | ||||
| Operation side | <.001[ | ||||||
| Right | 37 (52.9) | 5 (11.1) | |||||
| Left | 33 (47.1) | 40 (88.9) | |||||
| Abdominal operation history | 28 (40.0) | 12 (26.7) | .143 | ||||
| Receiver characteristics | |||||||
| Gender | .363 | ||||||
| Male | 55 (78.6) | 32 (71.1) | |||||
| Female | 15 (21.4) | 13 (28.9) | |||||
| Age (y) | 39.1 (16.2) | 38 (2–76) | 36.2 (15.4) | 33 (4–62) | .346 | ||
BMI = body mass index; LLDN = laparoscopic living-donor nephrectomy; PO = postoperative; TVNALDN = transvaginal natural orifice transluminal endoscopic surgery–assisted living-donor nephrectomy.
Statistically significant.
Operative Characteristics and Receiver Outcomes in Laparoscopic Versus Transvaginal Nephrectomy Groups
| LLDN[ | TVNALDN[ | ||||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Median (Minimum-Maximum) | n (%) | Mean (SD) | Median (Minimum-Maximum) | n (%) | ||
| Transplantation | |||||||
| Warm ischemia (s) | 176.5 (61.3) | 165 (77–414) | 182.5 (38.9) | 177 (112–261) | .193 | ||
| Cold ischemia (min) | 42.0 (15.1) | 42 (19–91) | 41.1 (10.7) | 41.5 (24–69) | .965 | ||
| No. of arterial anastomoses | 1.2 (0.4) | 1 (1–2) | 1.2 (0.4) | 1 (1–2) | .342 | ||
| No. of venous anastomoses | 1.1 (0.4) | 1 (1–3) | 1.0 (0.0) | 1 (1–1) | .029 | ||
| Donor operation time (min) | 151.4 (25.2) | 150 (100–210) | 156.7 (30.4) | 150 (110–270) | .503 | ||
| Length of hospitalization (d) | 2.7 (0.4) | 2 (2–5) | 2.7 (0.5) | 2 (1–5) | .973 | ||
| VAS[ | 2 (0.5) | 2 (1–6) | 1.5 (0.5) | 1.5 (1–5) | .786 | ||
| Serum creatinine (mg/dL) | |||||||
| At discharge | 1.36 (0.50) | 1.31 (0.35–3.42) | 1.24 (0.54) | 1.22 (0.31–3.62) | .852 | ||
| 6 mo postoperatively | 1.49 (0.58) | 1.39 (0.41–3.03) | 1.40 (0.67) | 1.19 (0.72–3.25) | .159 | ||
| 12 mo postoperatively | 1.35 (0.41) | 1.34 (0.44–2.27) | 1.35 (0.63) | 1.12 (0.76–2.32) | .734 | ||
| Receiver outcome | |||||||
| Major complication | 1 (1.4) | 2 (4.4) | .560 | ||||
| Graft loss[ | 2 (2.9) | 0 (0.0) | .519 | ||||
| Death | 2 (2.9) | 0 (0.0) | .519 | ||||
LLDN = laparoscopic living-donor nephrectomy; TVNALDN = transvaginal natural orifice transluminal endoscopic surgery–assisted living-donor nephrectomy; VAS = visual analog scale.
One of these patients has died and therefore is also listed in the “Death” category.